Aito Ueno, PhD

University of Calgary
2500 University Dr. NW
HSC 1838
Calgary, AB
Canada T2N1N4

Any personal financial relationships? No

1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.

2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).

3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.

4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".

Signed on 02/09/2015 by Aito Ueno

Papers:
T.53 Reduced in vitro Polarization of Salmonella-Specific IL-17 Secreting CD4+ T (Th17) cells by Salmonella-Infected Dendritic cells Derived from Crohn’s Disease Patients
T.54 Differential Effects of Cigarette Smoke Extract upon in vitro Polarization of Salmonella-Specific IFN-gamma Secreting CD4+ T (Th1) cells by Dendritic Cells from Crohn’s Disease Patients and Healthy Controls
T.58 Cumulative Risk Variant SNPs in ATG16L1 Locus are Associated with Reduced Ability of Salmonella Infected Dendritic Cells to Generate Autologous Bacterial-Specific Foxp3+ Regulatory T (Treg) cells

	1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.
	2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).
	3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.
	4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".